Literature DB >> 24527103

Venous ulcers: new options in treatment: minimally invasive vein surgery.

Honesto Poblete1, Steven Elias2.   

Abstract

Venous disease has a spectrum of presentations. The most advanced state of chronic venous insufficiency (CVI) managed by wound care specialists being ulceration of the lower extremity. The goal of all treatments for advanced venous disease is to decrease ambulatory venous hypertension. Treatment can be divided into exogenous and endogenous methods. Exogenous methods include those applied externally such as compression, elevation, debridement and wound dressings. Endogenous methods treat the underlying venous pathology either due to venous valvular dysfunction or venous obstruction leading to venous hypertension. Recently, significant advances in endogenous methods have evolved. The development of a new concept, minimally invasive vein surgery (MIVS), has improved upon traditional, open, invasive treatments of venous disease. MIVS techniques are performed percutaneously, with minimal anesthesia, no incisions and rarely require hospital admission. This article summarizes the concept of MIVS, describes each method of MIVS and its complementary role in the management of venous leg ulcers patients.

Entities:  

Keywords:  MIVS; PAPs; SEPS; laser ablation; minimally invasive vein surgery; perforator ablation; radiofrequency ablation; venous ulcer

Year:  2009        PMID: 24527103      PMCID: PMC3478919          DOI: 10.1016/j.jcws.2008.10.004

Source DB:  PubMed          Journal:  J Am Col Certif Wound Spec        ISSN: 1876-4983


  35 in total

1.  Ultrasound guided sclerotherapy (USGS) for perforating veins (PV).

Authors:  J J Guex
Journal:  Hawaii Med J       Date:  2000-06

Review 2.  Minimally invasive vein surgery: its role in the treatment of venous stasis ulceration.

Authors:  Steven M Elias; Krista L Frasier
Journal:  Am J Surg       Date:  2004-07       Impact factor: 2.565

3.  Early results and feasibility of incompetent perforator vein ablation by endovenous laser treatment.

Authors:  Thomas M Proebstle; Sylvia Herdemann
Journal:  Dermatol Surg       Date:  2007-02       Impact factor: 3.398

4.  Mid-term recurrence rate of incompetent perforating veins after combined superficial vein surgery and subfascial endoscopic perforating vein surgery.

Authors:  Florian Roka; Michael Binder; Kornelia Bohler-Sommeregger
Journal:  J Vasc Surg       Date:  2006-08       Impact factor: 4.268

5.  Results of the national pilot screening program for venous disease by the American Venous Forum.

Authors:  Robert B McLafferty; Joanne M Lohr; Joseph A Caprini; Marc A Passman; Frank T Padberg; Thom W Rooke; Ruth L Bush; Aamir A Zakaria; William R Flinn; Bo G Eklof; Michael C Dalsing; Steven J Markwell; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

6.  Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.

Authors:  Alessandro Frullini; Attilio Cavezzi
Journal:  Dermatol Surg       Date:  2002-01       Impact factor: 3.398

7.  Endoscopic versus open subfascial division of incompetent perforating veins in the treatment of venous leg ulceration: a randomized trial.

Authors:  E G Pierik; H van Urk; W C Hop; C H Wittens
Journal:  J Vasc Surg       Date:  1997-12       Impact factor: 4.268

Review 8.  Revision of the CEAP classification for chronic venous disorders: consensus statement.

Authors:  Bo Eklöf; Robert B Rutherford; John J Bergan; Patrick H Carpentier; Peter Gloviczki; Robert L Kistner; Mark H Meissner; Gregory L Moneta; Kenneth Myers; Frank T Padberg; Michel Perrin; C Vaughan Ruckley; Philip Coleridge Smith; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2004-12       Impact factor: 4.268

9.  Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: lessons learned from the North American subfascial endoscopic perforator surgery registry. The North American Study Group.

Authors:  P Gloviczki; J J Bergan; J M Rhodes; L G Canton; S Harmsen; D M Ilstrup
Journal:  J Vasc Surg       Date:  1999-03       Impact factor: 4.268

10.  Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial.

Authors:  Jamie R Barwell; Colin E Davies; Jane Deacon; Kate Harvey; Julia Minor; Antonio Sassano; Maxine Taylor; Jenny Usher; Clare Wakely; Jonathan J Earnshaw; Brian P Heather; David C Mitchell; Mark R Whyman; Keith R Poskitt
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

View more
  1 in total

1.  Protocol for a systematic review and meta-analysis of interventions for pathologic perforator veins in chronic venous disease.

Authors:  Melissa Andreia de Moraes Silva; Ronald Luiz Gomes Flumignan; Fausto Miranda; Rodolfo Souza Cardoso; Seleno Glauber de Jesus Silva; Henrique Jorge Guedes; Luis Carlos Uta Nakano
Journal:  BMJ Open       Date:  2019-05-01       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.